e-learning
resources
Glasgow 2004
Tuesday 07.09.2004
Clinical pathobiology of interstitial lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Bronchiolitis as a component in idiopathic pulmonary fibrosis and idiopathic interstitial pneumonias: clinico-pathological characteristics
V. V. Kraeva, E. A. Kogan, B. M. Kornev, E. N. Popova, V. V. Denguin, V. V. Fomin (Moscow, Russia)
Source:
Annual Congress 2004 - Clinical pathobiology of interstitial lung diseases
Session:
Clinical pathobiology of interstitial lung diseases
Session type:
Thematic Poster Session
Number:
3316
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. V. Kraeva, E. A. Kogan, B. M. Kornev, E. N. Popova, V. V. Denguin, V. V. Fomin (Moscow, Russia). Bronchiolitis as a component in idiopathic pulmonary fibrosis and idiopathic interstitial pneumonias: clinico-pathological characteristics. Eur Respir J 2004; 24: Suppl. 48, 3316
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Immunogenetic background of children´s idiopathic interstitial pneumonias and adult idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010
The classification, natural history and radiological/histological appearance of idiopathic pulmonary fibrosis and the other idiopathic interstitial pneumonias
Source: Eur Respir Rev 2008; 17: 108-115
Year: 2008
Non-IPF idiopathic interstitial pneumonias
Source: School Course 2014 - Interstitial lung diseases
Year: 2014
Clinical features of usual interstitial pneumonia-correlation between idiopathic pulmonary fibrosis and connective tissue disease associated with usual interstitial pneumonia
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Difference of the clinical characteristics and outcome between interstitial lung disease with dermatomyositis and idiopathic interstitial pneumonia
Source: International Congress 2017 – Lung function testing
Year: 2017
Clinical significance of histological classification of idiopathic interstitial pneumonia
Source: Eur Respir J 2002; 19: 275-283
Year: 2002
Cryptogenic fibrosing alveolitis/idiopathic pulmonary fibrosis
Source: Eur Respir J 2001; 18: 43S-55S
Year: 2001
Clinical course and morphological signs of idiopathic pulmonary fibrosis and interstitial pneumonias
Source: Eur Respir J 2004; 24: Suppl. 48, 536s
Year: 2004
Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature
Source: Eur Respir Rev 2012 21: 355-361
Year: 2012
Non-pulmonary comorbidities in idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Idiopathic pulmonary fibrosis - IPF
Source: Respipedia Article
Year: 2018
Idiopathic non-specific interstitial pneumonia (NSIP): is it an autoimmune clinical entity?
Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases
Year: 2007
Idiopathic pulmonary fibrosis (IPF) and idiopathic nonspecific interstitial pneumonia (NSIP): what treatment and for whom?
Source: Annual Congress 2006 - Usual interstitial pneumonia (UIP) and nonspecific interstitial pneumonia (NSIP), idiopathic or not: new concepts in diagnosis and treatment
Year: 2006
Clinical features of patients with idiopathic pulmonary upper lobe-dominant fibrosis
Source: International Congress 2016 – Orphan diseases I
Year: 2016
Idiopathic interstitial pneumonias
Source: Eur Respir Mon; 2009: 46: 87–111
Year: 2009
Survival of patients with biopsy-proven usual interstitial pneumonia and nonspecific interstitial pneumonia
Source: Eur Respir J 2002; 19: 1114-1118
Year: 2002
Interstitial lung abnormalities with a diagnosis of idiopathic pulmonary fibrosis
Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia
Year: 2021
Exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2016 – Russia Session
Year: 2016
Pulmonary fibrosis: “idiopathic” is not “cryptogenic”
Source: Eur Respir J, 53 (3) 1900400; 10.1183/13993003.00400-2019
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept